Home > Insider Trading > Filing (0001567619-18-002677)

Filing Details

Accession Number:: 0001567619-18-002677
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-09-14 18:17:15
Reporting Period:: 2018-09-12

Accepted Time:: 2018-09-14 18:17:15
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1581720	Loxo Oncology Inc.	LOXO	Pharmaceutical Preparations (2834)	462996673

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1612312	H. Joshua Bilenker	C/O Loxo Oncology, Inc. One Landmark Square, Suite 1122 Stamford CT 06901	President & Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2018-09-12	10,000	$1.18	145,407	No	4	M	Direct
Common Stock	Disposition	2018-09-12	700	$164.16	144,707	No	4	S	Direct
Common Stock	Disposition	2018-09-12	3,700	$165.18	141,007	No	4	S	Direct
Common Stock	Disposition	2018-09-12	2,400	$166.49	138,607	No	4	S	Direct
Common Stock	Disposition	2018-09-12	1,800	$167.38	136,807	No	4	S	Direct
Common Stock	Disposition	2018-09-12	800	$168.51	136,007	No	4	S	Direct
Common Stock	Disposition	2018-09-12	200	$169.89	135,807	No	4	S	Direct
Common Stock	Disposition	2018-09-12	400	$171.08	135,407	No	4	S	Direct
Common Stock	Acquisiton	2018-09-13	7,473	$1.18	142,880	No	4	M	Direct
Common Stock	Acquisiton	2018-09-13	2,527	$3.65	145,407	No	4	M	Direct
Common Stock	Disposition	2018-09-13	5,636	$165.43	139,771	No	4	S	Direct
Common Stock	Disposition	2018-09-13	3,402	$166.52	136,369	No	4	S	Direct
Common Stock	Disposition	2018-09-13	962	$167.32	135,407	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (Right to Buy)	Disposition	2018-09-12	10,000	$0.00	10,000	$1.18
Common Stock	Employee Stock Option (Right to Buy)	Disposition	2018-09-13	7,473	$0.00	7,473	$1.18
Common Stock	Employee Stock Option (Right to Buy)	Disposition	2018-09-13	2,527	$0.00	2,527	$3.65

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
63,932	2023-11-14	No	4	M	Direct
56,459	2023-11-14	No	4	M	Direct
92,985	2024-06-18	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	30,000	Indirect	By Joshua H. Bilenker, ttee Joshua Bilenker 2018 GRAT, dated 06/20/2018

Footnotes

The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person.
Represents the aggregate of sales effected on the same day at different prices.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $163.75 to $164.7499 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $164.75 to $165.7499 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $166.02 to $167.0199 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $167.04 to $168.0399 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $168.06 to $169.0599 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $169.48 to $170.4799 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $170.68 to $171.6799 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $165.02 to $166.0199 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $166.02 to $167.0199 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $167.18 to $168.1799 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The options have fully vested and are immediately exercisable.
The stock option vests and becomes exercisable in 48 equal monthly installments beginning on the vesting commencement date, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.